Projects P01, P02, P03

    Research Area 1: MHC-I-mediated recognition of CMV by T cells and NK cells


    Integrative analyses of CMV translatomes and MHC-I ligandomes Prof. Dr. Lars Dölken

    Prof. Dr. Florian Erhard
    Virology and Immunobiology, University of Würzburg


    Solving the m04 paradox: Evasion of missing-self recognition and CD8 T cell killing by MAT uORF Dr. Vanda Juranic Lisnic

    Prof. Dr. Stipan Jonjic, PhD
    University of Rijeka (Croatia)


    HCMV manipulation of antigen presentation by HLA-E by US10 Dr. Anne Halenius University of Freiburg

    Projects P04, P05, P06

    Research Area 2: Mechanisms defining T cell / NK cell activation and function

    P04 Impact of HCMV infection on professional antigen presenting cells Prof. Dr. Britta Eiz-Vesper

    Prof. Dr. Ulrich Kalinke
    Hannover Medical School

    Twincore Hannover
    P05 Role of NFAT signaling in memory inflation and T cell-mediated immune protection against CMV Prof. Dr. Luka Cicin-Sain

    PD. Dr. Friederike Berberich-Siebelt
    HZI Braunschweig

    University of Würzburg
    P06 Optimizing immune cell-based protection against CMV in preclinical models Prof. Dr. Reinhold Förster Hannover Medical School

    Projects P07, P08, P09

    Research Area 3: Improving immunological control of CMV for clinical interventions

    P07 Development of an HCMV vaccine utilizing knowledge of viral immuno­modulatory functions Prof. Dr. Martin Messerle Hannover Medical School
    P08 Impact of HCMV-encoded FcγR antagonists on innate immune cell function Prof. Dr. Hartmut Hengel University Hospital Freiburg
    P09 Personalized medicine - Risk stratification and prevention of HCMV-related disease in transplant patients based on MHC-I-bound peptidome analysis Prof. Dr. Hermann Einsele

    Dr. Sabrina Kraus
    University Hospital Würzburg

    University Hospital Würzburg